NEWS DETAIL

La FDA aprueba Lumakras® (Sotorasib) en combinación con Vectibix® (Panitumumab) para el cáncer colorrectal metastásico con mutación KRAS G12C quimiorresistente – PR Newswire

FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER PR Newswire

Información médica July 20, 2026

该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。

Productos relacionados con este articulo

Estos productos se asociaron automaticamente a partir del titulo, el resumen y el contenido del articulo.

Preguntas frecuentes

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Sotorasib – Comprar en línea SOTOLDX Sotorasib 120 mg.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.